Globeflex Capital L P Invests $1.86 Million in Guardian Pharmacy Services, Inc. $GRDN

Globeflex Capital L P acquired a new position in Guardian Pharmacy Services, Inc. (NYSE:GRDN – Free Report) in the second quarter, Holdings Channel reports. The fund acquired 44,354 shares of the company’s stock, valued at approximately $1,857,000.

A number of other hedge funds have also recently made changes to their positions in GRDN. Ameritas Investment Partners Inc. boosted its position in Guardian Pharmacy Services by 26.5% during the third quarter. Ameritas Investment Partners Inc. now owns 1,647 shares of the company’s stock valued at $43,000 after purchasing an additional 345 shares in the last quarter. California State Teachers Retirement System lifted its position in Guardian Pharmacy Services by 3.4% during the fourth quarter. California State Teachers Retirement System now owns 17,983 shares of the company’s stock valued at $541,000 after acquiring an additional 593 shares during the last quarter. Police & Firemen s Retirement System of New Jersey lifted its position in Guardian Pharmacy Services by 20.4% during the fourth quarter. Police & Firemen s Retirement System of New Jersey now owns 6,070 shares of the company’s stock valued at $183,000 after acquiring an additional 1,028 shares during the last quarter. Price T Rowe Associates Inc. MD boosted its stake in Guardian Pharmacy Services by 13.4% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 11,885 shares of the company’s stock valued at $358,000 after acquiring an additional 1,409 shares in the last quarter. Finally, Clearstead Advisors LLC boosted its stake in Guardian Pharmacy Services by 196.3% in the fourth quarter. Clearstead Advisors LLC now owns 2,628 shares of the company’s stock valued at $79,000 after acquiring an additional 1,741 shares in the last quarter.

Guardian Pharmacy Services Stock Performance

Shares of GRDN opened at $37.58 on Tuesday. The business’s 50-day moving average is $40.33 and its two-hundred day moving average is $37.79. The company has a market capitalization of $1.87 billion, a P/E ratio of 36.48, a P/E/G ratio of 1.96 and a beta of 0.11. Guardian Pharmacy Services, Inc. has a fifty-two week low of $23.14 and a fifty-two week high of $47.02.

Guardian Pharmacy Services (NYSE:GRDN – Get Free Report) last posted its earnings results on Thursday, August 6th. The company reported $0.29 EPS for the quarter, topping the consensus estimate of $0.26 by $0.03. Guardian Pharmacy Services had a return on equity of 29.97% and a net margin of 4.50%.The firm had revenue of $351.77 million for the quarter, compared to analyst estimates of $340.45 million. Analysts forecast that Guardian Pharmacy Services, Inc. will post 1.19 EPS for the current year.

Wall Street Analysts Forecast Growth

GRDN has been the topic of several research analyst reports. Weiss Ratings upgraded Guardian Pharmacy Services from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday. Zacks Research downgraded shares of Guardian Pharmacy Services from a “strong-buy” rating to a “hold” rating in a research report on Monday, May 11th. Wall Street Zen upgraded shares of Guardian Pharmacy Services from a “hold” rating to a “buy” rating in a research note on Sunday, August 9th. Oppenheimer upped their target price on Guardian Pharmacy Services from $43.00 to $49.00 and gave the company an “outperform” rating in a research report on Friday, August 7th. Finally, Truist Financial raised their target price on Guardian Pharmacy Services from $43.00 to $47.00 and gave the stock a “buy” rating in a research note on Wednesday, June 17th. Eight research analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $43.83.

View Our Latest Research Report on Guardian Pharmacy Services

About Guardian Pharmacy Services

(Free Report)

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.

Featured Stories

• Five stocks we like better than Guardian Pharmacy Services
• Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
• Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
• Snowflake Could Be Headed for New Highs Despite Insider Selling
• MongoDB Is Surging—And the Next Catalyst Is Almost Here

Want to see what other hedge funds are holding GRDN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Guardian Pharmacy Services, Inc. (NYSE:GRDN – Free Report).